Adriana L Smit1, Verena A Lambermont2, Robert J Stokroos3, Lucien J C Anteunis3, Michelene N Chenault4, Simone M Schaefer5, Luke W G Schoenmakers5, Bernd Kremer6, Boris W Kramer7. 1. Department of Otorhinolaryngology, Head and Neck Surgery, Maastricht University Medical Centre, Maastricht, the Netherlands School for Mental Health and Neuroscience, Maastricht University, Maastricht, the Netherlands a.l.smit-9@umcutrecht.nl. 2. Department of Pediatrics, Maastricht University Medical Centre, Maastricht, the Netherlands. 3. Department of Otorhinolaryngology, Head and Neck Surgery, Maastricht University Medical Centre, Maastricht, the Netherlands School for Mental Health and Neuroscience, Maastricht University, Maastricht, the Netherlands. 4. Department of Otorhinolaryngology, Head and Neck Surgery, Maastricht University Medical Centre, Maastricht, the Netherlands School for Mental Health and Neuroscience, Maastricht University, Maastricht, the Netherlands Department of Methodology and Statistics, Maastricht University, Maastricht, the Netherlands. 5. Department of Otorhinolaryngology, Head and Neck Surgery, Maastricht University Medical Centre, Maastricht, the Netherlands. 6. Department of Otorhinolaryngology, Head and Neck Surgery, Maastricht University Medical Centre, Maastricht, the Netherlands School of Oncology and Developmental Biology, Maastricht University, Maastricht, the Netherlands. 7. School for Mental Health and Neuroscience, Maastricht University, Maastricht, the Netherlands Department of Pediatrics, Maastricht University Medical Centre, Maastricht, the Netherlands School of Oncology and Developmental Biology, Maastricht University, Maastricht, the Netherlands.
Abstract
BACKGROUND: Fetal exposure to in utero inflammation such as chorioamnionitis is related to central nervous system injury. We hypothesized that chorioamnionitis can provoke inflammatory changes in the perilymph and alter hearing outcome. METHODS: Pregnant ewes were randomized into 2 groups: intrauterine injection with lipopolysaccharide (LPS; n = 19) or saline (n = 21). In the first experiment, fetal perilymph samples were taken for cytokine analysis. In the second experiment, consecutive bone-conducted auditory brain stem responses were obtained from 1 to 7 months after birth. RESULTS: Perilymph samples showed a significant elevation in interleukin 8 in the LPS group. Auditory brain stem response analysis demonstrated higher response thresholds and a prolongation of absolute peak V and interpeak intervals I to V and III to V in the LPS group compared to sham treatment. CONCLUSION: Our study confirms the hypothesis that an intrauterine inflammation by LPS can result in a fetal perilymphatic inflammatory response and functional impaired hearing outcomes after birth in a sheep model.
BACKGROUND: Fetal exposure to in utero inflammation such as chorioamnionitis is related to central nervous system injury. We hypothesized that chorioamnionitis can provoke inflammatory changes in the perilymph and alter hearing outcome. METHODS: Pregnant ewes were randomized into 2 groups: intrauterine injection with lipopolysaccharide (LPS; n = 19) or saline (n = 21). In the first experiment, fetal perilymph samples were taken for cytokine analysis. In the second experiment, consecutive bone-conducted auditory brain stem responses were obtained from 1 to 7 months after birth. RESULTS: Perilymph samples showed a significant elevation in interleukin 8 in the LPS group. Auditory brain stem response analysis demonstrated higher response thresholds and a prolongation of absolute peak V and interpeak intervals I to V and III to V in the LPS group compared to sham treatment. CONCLUSION: Our study confirms the hypothesis that an intrauterine inflammation by LPS can result in a fetal perilymphatic inflammatory response and functional impaired hearing outcomes after birth in a sheep model.
Authors: Nicoletta Di Simone; Fiorella Di Nicuolo; Riccardo Marana; Roberta Castellani; Francesco Ria; Manuela Veglia; Giovanni Scambia; Daniel Surbek; Eytan Barnea; Martin Mueller Journal: PLoS One Date: 2017-07-12 Impact factor: 3.240